Exogenous NAD+ administration significantly protects against myocardial ischemia/reperfusion injury in rat model

American Journal of Translational Research

Volumn 8, Issue 8, 2016, Pages 3342-3350

  Zhang, Youjun ^a   Wang, Ban ^a   Fu, Xingli ^b   Guan, Shaofeng ^a   Han, Wenzheng ^a   Zhang, Jie ^a   Gan, Qian ^a   Fang, Weiyi ^a   Ying, Weihai ^a   Qu, Xinkai ^a  

^a SHANGHAI JIAO TONG UNIVERSITY   (China)

^b JIANGSU UNIVERSITY   (China)

Author keywords

Antioxidation; Apoptosis; Infarction; Myocardial ischemia reperfusion; NAD+

Indexed keywords

CASPASE 3; MANGANESE SUPEROXIDE DISMUTASE; NICOTINAMIDE ADENINE DINUCLEOTIDE; PEROXIDASE; PROTEIN BAX; PROTEIN BCL XL;

ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; APOPTOSIS; ARTICLE; CARDIAC TROPONIN 1 CLIA KIT; CONTROLLED STUDY; HEART INFARCTION; HEART MUSCLE ISCHEMIA; IMMUNOFLUORESCENCE TEST; IMMUNOHISTOCHEMISTRY; IMMUNOPRECIPITATION; MALE; NONHUMAN; RAT; REPERFUSION INJURY; TUNEL ASSAY; WESTERN BLOTTING;

EID: 84983238426     PISSN: None     EISSN: 19438141     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Writing Group Members, Mozaffarian D, Benjamin EJ, Go AS, Arnett DK, Blaha MJ, Cushman M, Das SR, de Ferranti S, Després JP, Fullerton HJ, Howard VJ, Huffman MD, Isasi CR, Jiménez MC, Judd SE, Kissela BM, Lichtman JH, Lisabeth LD, Liu S, Mackey RH, Magid DJ, McGuire DK, Mohler ER 3rd, Moy CS, Muntner P, Mussolino ME, Nasir K, Neumar RW, Nichol G, Palaniappan L, Pandey DK, Reeves MJ, Rodriguez CJ, Rosamond W, Sorlie PD, Stein J, Towfighi A, Turan TN, Virani SS, Woo D, Yeh RW, Turner MB; American Heart Association Statistics Committee; Stroke Statistics Subcommittee. Heart Disease and Stroke Statistics-2016 Update: A Report From the American Heart Association. Circulation 2016; 133: e38-e360.
2. Hausenloy DJ and Yellon DM. Targeting Myocardial Reperfusion Injury-The Search Continues. N Engl J Med 2015; 373: 1073-1075.
3. Zhang J, Karcz MK, Nadtochiy SM and Brookes PS. High-throughput Screening Reveals the Mitochondrial Complex I Inhibitor Nornicotine is Cardioprotective in Ischemia-reperfusion Injury When Delivered at Reperfusion. Circ Res 2015; 117: A404-A404.
4. Moens AL, Claeys MJ, Timmermans JP and Vrints CJ. Myocardial ischemia/reperfusion-in-jury, a clinical view on a complex pathophysiological process. Int J Cardiol 2005; 100: 179-190.
5. Di Lisa F, Menabo R, Canton M, Barile M and Bernardi P. Opening of the Mitochondrial Permeability Transition Pore Causes Depletion of Mitochondrial and Cytosolic NAD+ and Is a Causative Event in the Death of Myocytes in Postischemic Reperfusion of the Heart. J Biol Chem 2000; 276: 2571-2575.
6. Hausenloy DJ and Yellon DM. Myocardial ischemia-reperfusion injury: a neglected therapeutic target. J Clin Invest 2013; 123: 92-100.
7. Magnone M, Bauer I, Poggi A, Mannino E, Sturla L, Brini M, Zocchi E, De Flora A, Nencioni A and Bruzzone S. NAD+ levels control Ca2+ store replenishment and mitogen-induced in crease of cytosolic Ca2+ by Cyclic ADP-ribose-dependent TRPM2 channel gating in human T lymphocytes. J Biol Chem 2012; 287: 21067-21081.
8. Peek CB, Affinati AH, Ramsey KM, Kuo HY, Yu W, Sena LA, Ilkayeva O, Marcheva B, Kobayashi Y, Omura C, Levine DC, Bacsik DJ, Gius D, Newgard CB, Goetzman E, Chandel NS, Denu JM, Mrksich M and Bass J. Circadian Clock NAD+ Cycle Drives Mitochondrial Oxidative Metabolism in Mice. Science 2013; 342: 1243417-1243417.
9. Chen H, Wang Y, Zhang J, Ma Y, Wang C, Zhou Y, Gu H and Ying W. NAD(+)-carrying mesopo-rous silica nanoparticles can prevent oxidative stress-induced energy failures of both rodent astrocytes and PC12 cells. PLoS One 2013; 8: e74100.
10. Canto C, Menzies KJ and Auwerx J. NAD(+) Metabolism and the Control of Energy Homeostasis: A Balancing Act between Mitochondria and the Nucleus. Cell Metab 2015; 22: 31-53.
11. Ying W, Wei G, Wang D, Wang Q, Tang X, Shi J, Zhang P and Lu H. Intranasal administration with NAD+ profoundly decreases brain injury in a rat model of transient focal ischemia. Front Biosci 2007; 12: 2728-2734.
12. Pillai VB, Sundaresan NR, Kim G, Gupta M, Rajamohan SB, Pillai JB, Samant S, Ravindra PV, Isbatan A and Gupta MP. Exogenous NAD Blocks Cardiac Hypertrophic Response via Activation of the SIRT3-LKB1-AMP-activated Kinase Pathway. J Biol Chem 2009; 285: 3133-3144.
13. Reagan WJ, York M, Berridge B, Schultze E, Walker D and Pettit S. Comparison of cardiac troponin I and T, including the evaluation of an ultrasensitive assay, as indicators of doxorubicin-induced cardiotoxicity. Toxicol Pathol 2013; 41: 1146-1158.
14. Apple FS, Murakami MM, Ler R, Walker D and York M. Analytical characteristics of commercial cardiac troponin I and T immunoassays in serum from rats, dogs, and monkeys with induced acute myocardial injury. Clin Chem 2008; 54: 1982-1989.
15. Snow-Lisy DC, Sabanegh ES Jr, Samplaski MK, Morris VB and Labhasetwar V. Superoxide dis-mutase-loaded biodegradable nanoparticles targeted with a follicle-stimulating hormone peptide protect Sertoli cells from oxidative stress. Fertil Steril 2014; 101: 560-567.
16. Savalia K, Manickam DS, Rosenbaugh EG, Tian J, Ahmad IM, Kabanov AV and Zimmerman MC. Neuronal uptake of nanoformulated superoxide dismutase and attenuation of angiotensin II-dependent hypertension after central administration. Free Radic Biol Med 2014; 73: 299-307.
17. Nozik-Grayck E, Woods C, Taylor JM, Benninger RK, Johnson RD, Villegas LR, Stenmark KR, Harrison DG, Majka SM, Irwin D and Farrow KN. Selective depletion of vascular EC-SOD augments chronic hypoxic pulmonary hypertension. Am J Physiol Lung Cell Mol Physiol 2014; 307: L868-876.
18. Wang B, Ma Y, Kong X, Ding X, Gu H, Chu T and Ying W. NAD(+) administration decreases doxorubicin-induced liver damage of mice by enhancing antioxidation capacity and decreasing DNA damage. Chem Biol Interact 2014; 212: 65-71.
19. Tseliou E, Kanazawa H, Dawkins J, Gallet R, Kreke M, Smith R, Middleton R, Valle J, Marban L, Kar S, Makkar R and Marban E. Widespread Myocardial Delivery of Heart-Derived Stem Cells by Nonocclusive Triple-Vessel Intracor-onary Infusion in Porcine Ischemic Cardiomyopathy: Superior Attenuation of Adverse Remodeling Documented by Magnetic Resonance Imaging and Histology. PLoS One 2016; 11: e0144523.
20. Hausenloy DJ, Candilio L, Evans R, Ariti C, Jenkins DP, Kolvekar S, Knight R, Kunst G, Laing C, Nicholas J, Pepper J, Robertson S, Xenou M, Clayton T and Yellon DM. Remote Ischemic Preconditioning and Outcomes of Cardiac Surgery. N Engl J Med 2015; 373: 1408-1417.
21. Tomaselli GF and Barth AS. Sudden cardio arrest: oxidative stress irritates the heart. Nat Med 2010; 16: 648-649.
22. Qiao Z, Ma J and Liu H. Evaluation of the antioxidant potential of Salvia miltiorrhiza ethanol extract in a rat model of ischemia-reperfusion injury. Molecules 2011; 16: 10002-10012.
23. Yu L, Li F, Zhao G, Yang Y, Jin Z, Zhai M, Yu W, Zhao L, Chen W, Duan W and Yu S. Protective effect of berberine against myocardial ischemia reperfusion injury: role of Notch1/Hes1-PTEN/Akt signaling. Apoptosis 2015; 20: 796-810.
24. De Meyer SF, Savchenko AS, Haas MS, Schatzberg D, Carroll MC, Schiviz A, Dietrich B, Rottensteiner H, Scheiflinger F and Wagner DD. Protective anti-inflammatory effect of ADAMTS13 on myocardial ischemia/reperfusion injury in mice. Blood 2012; 120: 5217-5223.
25. Hsu CP, Zhai P, Yamamoto T, Maejima Y, Matsushima S, Hariharan N, Shao D, Takagi H, Oka S and Sadoshima J. Silent Information Regulator 1 Protects the Heart From Ischemia/ Reperfusion. Circulation 2010; 122: 2170-2182.
26. Pu J, Yuan A, Shan P, Gao E, Wang X, Wang Y, Lau WB, Koch W, Ma XL and He B. Cardio-myocyte-expressed farnesoid-X-receptor is a novel apoptosis mediator and contributes to myocardial ischaemia/reperfusion injury. Eur Heart J 2013; 34: 1834-1845.
27. Wang Y, Lau W, Du Y, Gao E, Koch W and Ma XX. AdipoRon, the First Orally Active Adiponectin Receptor Activator, Attenuates Post-ischemic Myocardial Apoptosis via AMPK Activation and Oxidative Stress Reduction. Circ Res 2015; 117: A114-A114.
28. Zhang T, Zhang Y, Cui M, Jin L, Wang Y, Lv F, Liu Y, Zheng W, Shang H, Zhang J, Zhang M, Wu H, Guo J, Zhang X, Hu X, Cao CM and Xiao RP. CaMKII is a RIP3 substrate mediating ischemiaand oxidative stress-induced myocardial necroptosis. Nat Med 2016; 22: 175-182.